Yan Zihan, Fan Guangming, Li Hao, Jiao Yuming, Fu Weilun, Weng Jiancong, Huo Ran, Wang Jie, Xu Hongyuan, Wang Shuo, Cao Yong, Zhao Jizong
From the Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University.
China National Clinical Research Center for Neurological Diseases.
J Neuropathol Exp Neurol. 2021 Jan 1;80(1):71-78. doi: 10.1093/jnen/nlaa126.
Brain arteriovenous malformations (bAVMs) are congenital anomalies of blood vessels that cause intracranial hemorrhage in children and young adults. Chromosomal rearrangements and fusion genes play an important role in tumor pathogenesis, though the role of fusion genes in bAVM pathophysiological processes is unclear. The aim of this study was to identify fusion transcripts in bAVMs and analyze their effects. To identify fusion transcripts associated with bAVM, RNA sequencing was performed on 73 samples, including 66 bAVM and 7 normal cerebrovascular samples, followed by STAR-Fusion analysis. Reverse transcription polymerase chain reaction and Sanger sequencing were applied to verify fusion transcripts. Functional pathway analysis was performed to identify potential effects of different fusion types. A total of 21 fusion transcripts were detected. Cathepsin C (CTSC)-Ras-Related Protein Rab-38 (RAB38) was the most common fusion and was detected in 10 of 66 (15%) bAVM samples. In CTSC-RAB38 fusion-positive samples, CTSC and RAB38 expression was significantly increased and activated immune/inflammatory signaling. Clinically, CTSC-RAB38 fusion bAVM cases had a higher hemorrhage rate than non-CTSC-RAB38 bAVM cases (p < 0.05). Our study identified recurrent CTSC-RAB38 fusion transcripts in bAVMs, which may be associated with bAVM hemorrhage by promoting immune/inflammatory signaling.
脑动静脉畸形(bAVM)是血管的先天性异常,可导致儿童和年轻人颅内出血。染色体重排和融合基因在肿瘤发病机制中起重要作用,尽管融合基因在bAVM病理生理过程中的作用尚不清楚。本研究的目的是鉴定bAVM中的融合转录本并分析其作用。为了鉴定与bAVM相关的融合转录本,对73个样本进行了RNA测序,包括66个bAVM样本和7个正常脑血管样本,随后进行STAR-Fusion分析。应用逆转录聚合酶链反应和桑格测序来验证融合转录本。进行功能通路分析以确定不同融合类型的潜在作用。共检测到21种融合转录本。组织蛋白酶C(CTSC)-Ras相关蛋白Rab-38(RAB38)是最常见的融合类型,在66个bAVM样本中的10个(15%)中检测到。在CTSC-RAB38融合阳性样本中,CTSC和RAB38表达显著增加并激活免疫/炎症信号。临床上,CTSC-RAB38融合的bAVM病例出血率高于非CTSC-RAB38的bAVM病例(p<0.05)。我们的研究在bAVM中鉴定出复发性CTSC-RAB38融合转录本,其可能通过促进免疫/炎症信号与bAVM出血相关。